Serious allegations of illegality, favouritism and market manipulation have surfaced before Parliament's Public Accounts Committee, as it examines the State's acquisition of pharmaceuticals in Trinidad and Tobago.
The Committee claims unlawful requirements were imposed on drug importers for nearly a decade — potentially benefitting a single company.
